Related Experiment Video
Updated: Jun 21, 2026

07:39
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
One thousand dollar assist heart pump for patients from developing countries.
1Jiangsu University, Biomedical Engineering Institute, Zhenjiang, 212013, China.
The Open Biomedical Engineering Journal
|August 8, 2009
Summary
A novel, low-cost artificial heart pump was developed for recovery or bridge to transplantation. This implantable centrifugal pump offers a 10-year lifespan and prevents thrombus formation, significantly reducing costs for advanced cardiac therapies.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Medical Technology Innovation
Background:
- High cost of existing artificial heart pumps limits widespread clinical application.
- Current devices often exceed 100,000 US Dollars, posing a significant financial barrier.
- Need for affordable alternatives for heart failure recovery and bridge to transplantation therapies.
Purpose of the Study:
- To develop a cost-effective artificial heart pump with a target price of 1000 US Dollars.
- To enhance the longevity and safety of implantable cardiac assist devices.
- To address the limitations of current artificial heart pumps in terms of price and durability.
Main Methods:
- Design of a radially driven centrifugal pump with a brushless DC motor and streamlined impeller.
- Implementation of a novel rolling bearing system using wear-proof polythene needles for extended service life (>10 years).
- Introduction of a special purge system with heparinized saline infusion to prevent thrombus formation within the bearing and pump.
Main Results:
- The developed heart pump achieved continuous laboratory operation for 14 months with no measurable bearing wear.
- The device demonstrated a 10-year service life potential due to its specialized bearing design.
- Animal experiments confirmed that 30 mL/hour fluid infusion effectively prevents thrombus formation.
- The fully implantable device weighs 150g, consumes 9.6W, delivers 9L/min blood flow against 120 mmHg, and achieves 24.7% peak efficiency.
Conclusions:
- The developed low-cost artificial heart pump shows significant promise for improving accessibility to advanced cardiac therapies.
- The innovative design, particularly the bearing and purge system, ensures durability and prevents thrombus formation.
- Successful animal and human trials indicate the potential of this device for clinical use in heart failure management.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

